Be the first to know

Never miss an update from CSL. Did you know that during reporting season, the announcements from ASX:CSL often move the market?

CSL (ASX:CSL) Company Logo

By joining StockLight, you agree to our Terms & Conditions and Privacy Policy
Create Alert Follow CSL

CSL (CSL)

AU ASX:CSL (122.6B)

277.15
+7.23 (2.61%)
4pm Monday Aug 03 AEST
LOADING
Loading price chart..

Summary

Current Price: $277.15
52w High/Low: $215.24 - 342.75
Market Cap: 122.6B
Price/Earnings: 42.61
Dividend Yield: 1.08%
Volume/Average: 1.2M - $933
CSL (ASX:CSL) Company Logo

Listed in 1994

Development, manufacturing and marketing of pharmaceutical and diagnostic products, cell culture media and human plasma fractions.
CSL (ASX:CSL) Company Logo

Development, manufacturing and marketing of pharmaceutical and diagnostic products, cell culture media and human plasma fractions.

Annual Reports

CSL Annual Report 2018/19 Sep 5th 2019
2019
(6.8mb)
CSL Annual Report to shareholders Sep 13th 2018
2018
(5.8mb)
Annual Report to Shareholders Sep 14th 2017
2017
(5.8mb)
Annual Report to shareholders Sep 8th 2016
2016
(5.5mb)
Annual Report to shareholders Sep 11th 2015
2015
(4.3mb)

Dividend History

Quantitative Ratios

Stock Ratios Locked
You viewed 3 companies today
Ratios will be unlocked
again tomorrow or;

Unlock these ratios,
configure alerts
and much more...

Download StockLight

All Ratios, Alerts and other features are available in our iOS and Android apps:
Download on iOS Download on Android

We are working on updating this web app to fully enable Quantitative Ratios. All other current web features including annual reports, price sensitive announcements, dividends and earnings transcripts are free to use here on our web app.
Dividend Yield
0.6%
 
1.1%
 
 
Industry Avg
CSL

ATTRACTIVE: CSL's dividend yield of 1.1% exceeds the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. more
Implied Growth
35.9%
 
7.7%
 
 
Industry Avg
CSL

ATTRACTIVE: CSL exhibits an implied growth ratio which is less than the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. CSL calculation: 10% - ($6.32 / $277.15) = 7.7% more
Price / Book
5.1
 
14.5
 
 
Industry Avg
CSL

UNATTRACTIVE: CSL exhibits a price/book ratio which exceeds the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. more
Price / Earnings
29.8
 
43.8
 
 
Industry Avg
CSL

UNATTRACTIVE: CSL's price/earnings ratio of 43.8 exceeds the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. more
Price / Sales
15.2
 
9.9
 
 
Industry Avg
CSL

ATTRACTIVE: CSL exhibits a price/sales ratio which is less than the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. more

Company News

Why I would buy and hold CSL and these ASX healthcare shares
August 3rd, 2020 - Motley Fool

Here's why I would buy and hold CSL Limited (ASX:CSL) and these ASX healthcare shares right now... The post Why I would buy and hold CSL and these ASX healthcare shares appeared first on Motley Fool Australia.

CSL and 1 other ASX 200 growth share to buy for long-term growth
August 3rd, 2020 - Motley Fool

Here we look 2 ASX 200 growth shares to buy for long-term growth: CSL Limited (ASX: CSL) and Blackmores Limited (ASX: BKL). The post CSL and 1 other ASX 200 growth share to buy for long-term growth appeared first on Motley Fool Australia.

Top ASX Stock Picks for August 2020
August 2nd, 2020 - Motley Fool

We asked our Foolish writers to pick their favourite ASX stocks to buy in August 2020. Here is what they came up with… The post Top ASX Stock Picks for August 2020 appeared first on Motley Fool Australia.

Top brokers name 3 ASX shares to buy next week
August 1st, 2020 - Motley Fool

Top brokers have named CSL Limited (ASX:CSL) and these ASX shares as buys for next week. Here's why they are bullish on these shares... The post Top brokers name 3 ASX shares to buy next week appeared first on Motley Fool Australia.

3 ASX LICs offering big dividend yields over 7%
August 1st, 2020 - Motley Fool

Here are 3 listed investment companies (LICs) that offer big dividend yields over 7%. One is WAM Leaders (ASX:WLE) which targets large caps. The post 3 ASX LICs offering big dividend yields over 7% appeared first on Motley Fool Australia.

Is the Woolworths share price in the buy zone?
July 31st, 2020 - Motley Fool

The Woolworths share price has lagged the performance of Coles so far this year. Is the supermarket giant now in the buy zone? The post Is the Woolworths share price in the buy zone? appeared first on Motley Fool Australia.

Brokers name 3 ASX 200 shares to buy right now
July 31st, 2020 - Motley Fool

Brokers have named CSL Limited (ASX:CSL) and these ASX 200 shares as buys this week. Here's why they are bullish on them... The post Brokers name 3 ASX 200 shares to buy right now appeared first on Motley Fool Australia.

3 underloved ASX healthcare shares with strong comeback potential
July 30th, 2020 - Motley Fool

I believe ASX healthcare shares are a solid gamble. Afterall, people are going to need to see doctors regardless of the state of the economy. The post 3 underloved ASX healthcare shares with strong comeback potential appeared first on Motley Fool Australia.